These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16224517)

  • 41. Evaluation of immunological responses in patients with ovarian cancer treated with the anti-idiotype vaccine ACA125 by determination of intracellular cytokines--a preliminary report.
    Reinartz S; Boerner H; Koehler S; Von Ruecker A; Schlebusch H; Wagner U
    Hybridoma; 1999 Feb; 18(1):41-5. PubMed ID: 10211787
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [In vitro study of 6B11GM to induce cellular immunity in patients with ovarian carcinoma].
    Yang F; Qian H; Feng J
    Zhonghua Fu Chan Ke Za Zhi; 1999 Nov; 34(11):660-3. PubMed ID: 11479947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients.
    Schlienger K; Chu CS; Woo EY; Rivers PM; Toll AJ; Hudson B; Maus MV; Riley JL; Choi Y; Coukos G; Kaiser LR; Rubin SC; Levine BL; Carroll RG; June CH
    Clin Cancer Res; 2003 Apr; 9(4):1517-27. PubMed ID: 12684428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A clinical trial of active immunotherapy with anti-idiotypic vaccine in nasopharyngeal carcinoma patients.
    Li G; Xie L; Zhou G; Fu H; Zhou J; Sun Q
    Chin Med J (Engl); 2002 Apr; 115(4):567-70. PubMed ID: 12133300
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Serological analysis of antibodies by anti-idiotypic monoclonal antibody 6B11 against ovarian carcinoma].
    Feng J; Lü J; Qian H
    Zhonghua Fu Chan Ke Za Zhi; 1996 Aug; 31(8):493-5. PubMed ID: 9275445
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Immunoprophylaxis of recombinant Mycobacterium vaccae secreted MPT64 of Mycobacterium tuberculosis].
    Bai YL; Xue Y; Wang LM; Fan AL; Zhang W; Kang J; He JJ; Xu ZK
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Mar; 25(3):211-4. PubMed ID: 19257983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection.
    Ferrari L; Martelli P; Saleri R; De Angelis E; Cavalli V; Bresaola M; Benetti M; Borghetti P
    Vet Immunol Immunopathol; 2013 Feb; 151(3-4):193-206. PubMed ID: 23228653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity.
    Peng P; Yan Y; Keng S
    Oncol Rep; 2011 Mar; 25(3):749-62. PubMed ID: 21181093
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [High-level expression of 6B11 ovarian carcinoma anti-idiotypic antibody scFv genes in E. Coli].
    Liu Y; Qian H; Huang H
    Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):221-3. PubMed ID: 11601044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. B16 cell lysates plus polyinosinic-cytidylic acid effectively eradicate melanoma in a mouse model by acting as a prophylactic vaccine.
    Lin B; Zhao H; Fan J; Xie F; Wang W; Ding X
    Mol Med Rep; 2014 Aug; 10(2):911-6. PubMed ID: 24840631
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses.
    Matsuzaki J; Tsuji T; Luescher IF; Shiku H; Mineno J; Okamoto S; Old LJ; Shrikant P; Gnjatic S; Odunsi K
    Sci Rep; 2015 Oct; 5():14896. PubMed ID: 26447332
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins.
    Kurihara K; Shimizu Y; Takamori A; Harashima N; Noji M; Masuda T; Utsunomiya A; Okamura J; Kannagi M
    J Immunol Methods; 2006 Jun; 313(1-2):61-73. PubMed ID: 16723135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional CD4(+) and CD8(+) T-cell responses induced by autologous mitomycin C treated Epstein-Barr virus transformed lymphoblastoid cell lines.
    Meij P; Bloemena E; Palmen N; Brink A; Vervoort MB; Meijer CJ; Middeldorp JM
    Cell Immunol; 2001 Feb; 208(1):25-33. PubMed ID: 11277616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autologous tumor vaccine modified with recombinant new castle disease virus expressing IL-7 promotes antitumor immune response.
    Zhao L; Mei Y; Sun Q; Guo L; Wu Y; Yu X; Hu B; Liu X; Liu H
    J Immunol; 2014 Jul; 193(2):735-45. PubMed ID: 24943214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Adjuvant effect of plasmid vector-expressed OX40L on candidate DNA vaccine against type B heptatitis].
    Du X; Kang Y; Wang X; Wang J; Zhao G; Wang B
    Wei Sheng Wu Xue Bao; 2009 Mar; 49(3):357-62. PubMed ID: 19623960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antitumor mechanism of recombinant murine interleukin-12 vaccine.
    Yin X; Yan X; Yang Q; Cao H; Liang H
    Cancer Biother Radiopharm; 2010 Jun; 25(3):263-8. PubMed ID: 20578831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-inflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritis.
    Blaschke S; Viereck V; Schwarz G; Klinger HM; Guerluek S; Müller GA
    Scand J Rheumatol; 2009; 38(4):235-9. PubMed ID: 19247848
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: a single-arm phase II study.
    Vermeij R; Leffers N; Hoogeboom BN; Hamming IL; Wolf R; Reyners AK; Molmans BH; Hollema H; Bart J; Drijfhout JW; Oostendorp J; van der Zee AG; Melief CJ; van der Burg SH; Daemen T; Nijman HW
    Int J Cancer; 2012 Sep; 131(5):E670-80. PubMed ID: 22139992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
    Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Paradoxical enhancement of CD8 T cell-dependent anti-tumor protection despite reduced CD8 T cell responses with addition of a TLR9 agonist to a tumor vaccine.
    Karan D; Krieg AM; Lubaroff DM
    Int J Cancer; 2007 Oct; 121(7):1520-8. PubMed ID: 17565748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.